• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Benefit

    PRESS RELEASE

    Arvinas`s Vepdegestrant Posters at 2024 San Antonio Symposium

    GLOBENEWSWIRE

    Arvinas & Pfizer announce updated clinical data from Ph1b Trial of Vepdegestrant

    INDINPHARMAPOST

    Arvinas, Pfizer Update Vepdegestrant + Palbociclib Phase 1b Data

    GLOBENEWSWIRE

    Arvinas Vepdegestrant Posters At ESMO Breast Cancer Congress 2024

    GLOBENEWSWIRE

    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib

    GLOBENEWSWIRE

    Arvinas and Pfizers Vepdegestrant (ARV-471) Receives FDA Fast Track Designation

    GLOBENEWSWIRE

    Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data

    GLOBENEWSWIRE

    Arvinas & Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.